Home Improvement & Health Care

The Lupus Foundation of America, Inc. (LFA) is seeking applications for its 2010 Gina M. Finzi Memorial Student Summer Fellowship Program. The purpose of these awards is to foster an interest among young investigators in lupus research under the supervision of an established in investigator. Undergraduate, graduate, and medical students are eligible to apply; however, preference is given to students with a college degree. It has been 50 years since the U.S. Food and Drug Administration (FDA) has approved a drug for lupus. The Gina M…

The Royal College of Nursing (RCN) Research Society today announced the shortlist for the Akinsanya Award 2010 for Innovation in Doctoral Studies in Nursing…

Psychologists will share the success of their ground-breaking back-to-work programme for the long term unemployed, Skills4Success, today, 13th January 2010, at the British Psychological Society’s Division of Occupational Psychology Annual Conference in Brighton. Chartered Psychologist Nancy Doyle will present the results and techniques used in the Skills4Success programme, which uses the latest psychological techniques to help its unemployed participants take control of their careers and acquire gainful employment…

Despite heavy damage to its own offices in Port-au-Prince UNICEF is ready to provide immediate support to the victims of the unfolding humanitarian crisis following the earthquake that hit Haiti today. In coordination with all other UN agencies present on the ground, UNICEF will provide supplies to allow access to adequate sanitation, safe water and basic health care. UNICEF is also preparing materials and staff so that children, tremendously vulnerable during natural catastrophes, are protected…

“We are saddened to learn of the devastating earthquake in Haiti. While relief efforts have begun, communications are extremely difficult and accurate information is still scarce, it is clear that the consequences are severe and many children are among the victims. Our hearts go out to the families whose lives have been so terribly impacted by this tragedy. “Early news reports indicate that schools have collapsed, homes destroyed, and hospitals overwhelmed by the large numbers of injured coming in for medical assistance…

BioMedReports.Com, the news portal which covers Wall Street’s biomedical sector and delivers financial and investment intelligence to a community of highly informed investors, is reporting Pfizer Inc. has announced that it has decided to discontinue the late-stage study of its lung cancer candidate figitumumab (CP-751,871) while Novelos’ (OTCBB: NVLT) pivotal Phase 3 trial, with a primary efficacy endpoint of improvement in median overall survival, continues across approximately 12 countries and 100 clinical sites…

The Food and Drug Administration (FDA) has informed Photocure that the new drug application (NDA) for Hexvix for detection of non-invasive papillary bladder cancer may be approved pending approval of the PMA for the Karl Storz photodynamic diagnosis system and final agreements between Photocure and FDA on labeling, and post-marketing commitments. The photodynamic diagnosis system is the blue light cystoscopy system that will be used with Hexvix on the US market. Photocure expects the pending issues to be agreed with FDA within the first half year of 2010…

A new strategy that researchers believe provides a more comprehensive screening of the entire chromosomal makeup of an embryo shows tremendous promise in the field of preimplantation genetic screening (PGS) according to a study published in the December issue of Fertility and Sterility. Forty-five infertile couples participated in the study with an average age of 37.7 years. Using a novel screening approach, researchers biopsied several cells from embryos five days after fertilization, also known as the blastocyst stage…

Biodel, Inc. (Nasdaq: BIOD) announced today that it has submitted a new drug application (NDA) to the U.S. Food and Drug Administration for clearance to market VIAject® as a treatment for diabetes. VIAject® is Biodel’s proprietary formulation of recombinant human insulin that is designed to be absorbed into the blood faster than currently marketed rapid-acting insulin analogs. It is Biodel’s most advanced product candidate and has been tested in more than 884 patients who participated in Phase 1, 2 and 3 clinical trials of the drug in the United States, Germany and India…

An international team of scientists has found that cells that protect nerves are likely to be the origins of a fatal cancer known as Devil Facial Tumour Disease (DFTD) that is spreading rapidly through populations of Tasmanian devils in Australia: if unchecked, scientists estimate the cancer, which is spread through biting, could wipe out the wild devil population within the next 30 years or so. The findings are the subject of a collaborative study led by Australian scientists that was published in the international journal Science on 1 January…